Related references
Note: Only part of the references are listed.Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity
Malgorzata Krzesniak et al.
CELLULAR SIGNALLING (2020)
TP53 gain-of-function mutation promotes inflammation in glioblastoma
Seok Won Ham et al.
CELL DEATH AND DIFFERENTIATION (2019)
Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis
Emmanuelle Saint-Germain et al.
CANCER RESEARCH (2019)
Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer
Jatin Sharma et al.
FRONTIERS IN PHARMACOLOGY (2019)
SIRT6 regulated nucleosomal occupancy affects Hexokinase 2 expression
Piyushi Gupta et al.
EXPERIMENTAL CELL RESEARCH (2017)
Tet-Mediated DNA Demethylation Is Required for SWI/ SNF-Dependent Chromatin Remodeling and Histone-Modifying Activities That Trigger Expression of the Sp7 Osteoblast Master Gene during Mesenchymal Lineage Commitment
Hugo Sepulveda et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy
Shunsuke Chikuma et al.
CANCER SCIENCE (2017)
Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells
Neil T. Pfister et al.
GENES & DEVELOPMENT (2015)
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
Jiajun Zhu et al.
NATURE (2015)
TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth
Svasti Haricharan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A MyD88-JAK1-STAT1 complex directly induces SOCS-1 expression in macrophages infected with Group A Streptococcus
Jinghua Wu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells
Amitabh Das et al.
EXPERIMENTAL CELL RESEARCH (2014)
Tumor Necrosis Factor Alpha-Induced Hypoxia-Inducible Factor 1α-β-Catenin Axis Regulates Major Histocompatibility Complex Class I Gene Activation through Chromatin Remodeling
Sadashib Ghosh et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
The Human TLR Innate Immune Gene Family Is Differentially Influenced by DNA Stress and p53 Status in Cancer Cells
Maria Shatz et al.
CANCER RESEARCH (2012)
Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma
Richa Tewari et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
p53-mediated heterochromatin reorganization regulates its cell fate decisions
Sathish Kumar Mungamuri et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
JMJD2A Promotes Cellular Transformation by Blocking Cellular Senescence through Transcriptional Repression of the Tumor Suppressor CHD5
Frederick A. Mallette et al.
CELL REPORTS (2012)
TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
Naoko Matsunaga et al.
MOLECULAR PHARMACOLOGY (2011)
p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation
Oleg Laptenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Biology of Chromatin Remodeling Complexes
Cedric R. Clapier et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
SOCS1 Links Cytokine Signaling to p53 and Senescence
Viviane Calabrese et al.
MOLECULAR CELL (2009)
Suppressor of cytokine signaling 1 inhibits IFN-γ inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation
Stefania Madonna et al.
FASEB JOURNAL (2008)
Reciprocal regulation of SOCS1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme
Hong Zhou et al.
CLINICAL CANCER RESEARCH (2007)
Transcription regulation by mutant p53
L. Weisz et al.
ONCOGENE (2007)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation
A Mansell et al.
NATURE IMMUNOLOGY (2006)
Toll-like receptors on tumor cells facilitate evasion of immune surveillance (Publication with Expression of Concern. See vol. 79, pg. 4305, 2019)
B Huang et al.
CANCER RESEARCH (2005)
IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site
D Hebenstreit et al.
JOURNAL OF IMMUNOLOGY (2003)
Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes
S Kadam et al.
MOLECULAR CELL (2003)
SOCS-1 participates in negative regulation of LPS responses
R Nakagawa et al.
IMMUNITY (2002)
Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes
S Saccani et al.
GENES & DEVELOPMENT (2002)
Impaired IFN-γ-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1
M Federici et al.
JOURNAL OF IMMUNOLOGY (2002)
SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription
D Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
H Yoshikawa et al.
NATURE GENETICS (2001)
Share Paper
